Prevalence of positive toxicology analysis from the French national registry for sudden unexpected infant death (Tox-MIN).

French national registry Sudden unexpected infant death child abuse toxicological analysis

Journal

Clinical toxicology (Philadelphia, Pa.)
ISSN: 1556-9519
Titre abrégé: Clin Toxicol (Phila)
Pays: England
ID NLM: 101241654

Informations de publication

Date de publication:
Jan 2022
Historique:
pubmed: 4 6 2021
medline: 31 3 2022
entrez: 3 6 2021
Statut: ppublish

Résumé

Sudden unexpected infant death (SUID) remains the leading cause of postnatal mortality in many countries. French and international guidelines recommend a thorough examination with toxicology studies. The main objective was to determine the prevalence of toxic detection and positive analyses. The secondary objectives were to describe the different toxics and compare children with positive (Tox+) and negative results (Tox-) with other SUID risk factors. We used the data registered from May 2015 to December 2018 by the French national SUID registry (OMIN). It collects data for all SUID cases admitted to any of the 35 participating French SUID referral centers. Of the 624 SUID cases registered in the OMIN, a post-mortem toxicological analysis was performed in 398 infants. Thirty-six patients (9%) were positives for expected (Etox+ ( The high rate of positive results warrants routine toxicology testing. The imputability of identified molecules is complicated by the presence of other known risk factors for SUID.

Sections du résumé

BACKGROUND BACKGROUND
Sudden unexpected infant death (SUID) remains the leading cause of postnatal mortality in many countries. French and international guidelines recommend a thorough examination with toxicology studies.
OBJECTIVES OBJECTIVE
The main objective was to determine the prevalence of toxic detection and positive analyses. The secondary objectives were to describe the different toxics and compare children with positive (Tox+) and negative results (Tox-) with other SUID risk factors.
DESIGN AND METHODS METHODS
We used the data registered from May 2015 to December 2018 by the French national SUID registry (OMIN). It collects data for all SUID cases admitted to any of the 35 participating French SUID referral centers.
RESULTS RESULTS
Of the 624 SUID cases registered in the OMIN, a post-mortem toxicological analysis was performed in 398 infants. Thirty-six patients (9%) were positives for expected (Etox+ (
CONCLUSION CONCLUSIONS
The high rate of positive results warrants routine toxicology testing. The imputability of identified molecules is complicated by the presence of other known risk factors for SUID.

Identifiants

pubmed: 34080518
doi: 10.1080/15563650.2021.1933005
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

38-45

Auteurs

Isabelle Claudet (I)

The Pediatric Emergency Department, Children's Hospital, Toulouse University Hospital (CHU), France.
UMR 1295, Inserm, Paul Sabatier University, UPS, Toulouse, France.

Sophie de Visme (S)

INSERM, CIC 1413, Nantes CHU, France.

Gilles Duthoit (G)

The Pediatric Mobile Care Unit (SMUR), Children's hospital, Toulouse CHU, France.

Lucile Barnet (L)

The Pediatric Mobile Care Unit (SMUR), Children's hospital, Toulouse CHU, France.

Claire Marchand-Tonel (C)

Director of the Health Division, IFRASS, Toulouse, France.
The LISST laboratory, Jean-Jaurès University, UT2J, Toulouse II, France.

Martin Chever (M)

The Pediatric Emergency Department, Children's Hospital, Toulouse University Hospital (CHU), France.

Elisabeth Daussac (E)

The Pediatric Mobile Care Unit (SMUR), Children's hospital, Toulouse CHU, France.

Camille Bréhin (C)

The Pediatric Emergency Department, Children's Hospital, Toulouse University Hospital (CHU), France.
UMR 1416, Inserm, IRSD, Toulouse, France.

Karine Levieux (K)

The Pediatric Emergency Unit, Children's Hospital, Nantes CHU, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH